{"DataElement":{"publicId":"3108377","version":"2","preferredName":"Endometrial Carcinoma FIGO 2009 Stage","preferredDefinition":"The extent of endometrial cancer in the body, based on staging criteria from the Federation of Gynecology and Obstetrics (FIGO).","longName":"3108351v1.0:3108365v1.1","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3108351","version":"1","preferredName":"Endometrial Neoplasm Stage","preferredDefinition":"Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3108349v1.0:2224086v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3108349","version":"1","preferredName":"Endometrial Neoplasm","preferredDefinition":"Tumor originating and limited to the endometrium at first stage","longName":"C3012","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial Neoplasm","conceptCode":"C3012","definition":"A benign, borderline, or malignant neoplasm that affects the endometrium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88885973-0D6F-EC2B-E040-BB89AD432554","latestVersionIndicator":"Yes","beginDate":"2010-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-08","modifiedBy":"ONEDATA","dateModified":"2010-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2224086","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63F1A4F-0A96-5494-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-03","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-05-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88885973-0D7D-EC2B-E040-BB89AD432554","latestVersionIndicator":"Yes","beginDate":"2010-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3108365","version":"1.1","preferredName":"Endometrial Carcinoma FIGO 2009 Stage","preferredDefinition":"A malignant tumor arising from the epithelium that lines the cavity of the uterine body.  The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases.  Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma.  Uterine bleeding is an initial clinical sign.  The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation. -- 2004_The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3108365v1.1","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"7","maxLength":"11","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage IVA","valueDescription":"FIGO Stage IVA","ValueMeaning":{"publicId":"3225664","version":"1","preferredName":"FIGO Stage IVA","longName":"3225664","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that invades the mucosa of bladder or rectum, and/or extends beyond the true pelvis; for endometrial cancer, it refers to cancer that invades the bladder mucosa and/or the bowel mucosa.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IVA","conceptCode":"C96262","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that invades the mucosa of bladder or rectum, and/or extends beyond the true pelvis; for endometrial cancer, it refers to cancer that invades the bladder mucosa and/or the bowel mucosa.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4EF9-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73C1C15-0435-D771-E040-BB89AD430AF5","beginDate":"2010-06-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"Stage IVB","valueDescription":"FIGO Stage IVB","ValueMeaning":{"publicId":"3225663","version":"1","preferredName":"FIGO Stage IVB","longName":"3225663","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer with distant metastases, including peritoneal involvement, involvement of the supraclavicular or mediastinal lymph nodes, and metastases to the lung, bone, or liver; for endometrial cancer, it refers to cancer with distant metastases, including metastases to the inguinal lymph nodes, intraperitoneal involvement, or metastases to the lung, bone, or liver.  Endometrial cancer metastases to the para-aortic lymph nodes, vagina, adnexa, or pelvic serosa are excluded from this stage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IVB","conceptCode":"C96263","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer with distant metastases, including peritoneal involvement, involvement of the supraclavicular or mediastinal lymph nodes, and metastases to the lung, bone, or liver; for endometrial cancer, it refers to cancer with distant metastases, including metastases to the inguinal lymph nodes, intraperitoneal involvement, or metastases to the lung, bone, or liver.  Endometrial cancer metastases to the para-aortic lymph nodes, vagina, adnexa, or pelvic serosa are excluded from this stage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4ED4-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73C1C15-043F-D771-E040-BB89AD430AF5","beginDate":"2010-10-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"Stage IV","valueDescription":"FIGO Stage IV","ValueMeaning":{"publicId":"3225665","version":"1","preferredName":"FIGO Stage IV","longName":"3225665","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that invades the mucosa of bladder or rectum, and/or extends beyond the true pelvis (FIGO stage IVA), or to cancer with distant metastases (FIGO stage IVB); for endometrial cancer, it refers to cancer that invades the bladder mucosa and/or the bowel mucosa (FIGO stage IVA), or to cancer with distant metastases (FIGO stage IVB).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IV","conceptCode":"C96261","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that invades the mucosa of bladder or rectum, and/or extends beyond the true pelvis (FIGO stage IVA), or to cancer with distant metastases (FIGO stage IVB); for endometrial cancer, it refers to cancer that invades the bladder mucosa and/or the bowel mucosa (FIGO stage IVA), or to cancer with distant metastases (FIGO stage IVB).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4F1E-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73C1C15-0449-D771-E040-BB89AD430AF5","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"Stage III","valueDescription":"FIGO Stage III","ValueMeaning":{"publicId":"3225671","version":"1","preferredName":"FIGO Stage III","longName":"3225671","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that extends to the pelvic wall, and/or involves the lower third of vagina, and/or causes hydronephrosis or non-functioning kidney; for endometrial cancer, FIGO stage III is subdivided into stages IIIA and IIIB; in FIGO stage IIIA, there is involvement of the serosa and/or the adnexa; for FIGO stage IIIB, there is vaginal or parametrial involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage III","conceptCode":"C96255","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that extends to the pelvic wall, and/or involves the lower third of vagina, and/or causes hydronephrosis or non-functioning kidney; for endometrial cancer, FIGO stage III is subdivided into stages IIIA and IIIB; in FIGO stage IIIA, there is involvement of the serosa and/or the adnexa; for FIGO stage IIIB, there is vaginal or parametrial involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4FFC-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73C1C15-0453-D771-E040-BB89AD430AF5","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"Stage I","valueDescription":"FIGO Stage I","ValueMeaning":{"publicId":"3225682","version":"1","preferredName":"FIGO Stage I","longName":"3225682","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to invasive cancer that is confined to the cervix; for endometrial cancer, it refers to cancer confined to the corpus uteri with no or less than one-half myometrial invasion (IA) or invasion of one-half or more of the myometrium (IB).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage I","conceptCode":"C96244","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to invasive cancer that is confined to the cervix; for endometrial cancer, it refers to cancer confined to the corpus uteri with no or less than one-half myometrial invasion (IA) or invasion of one-half or more of the myometrium (IB).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-5193-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73C1C15-045D-D771-E040-BB89AD430AF5","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"Stage II","valueDescription":"FIGO Stage II","ValueMeaning":{"publicId":"3225674","version":"1","preferredName":"FIGO Stage II","longName":"3225674","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that invades beyond the cervix, but not to the pelvic wall or lower third of the vagina; for endometrial cancer, it refers to cancer that invades the stromal connective tissue of the cervix, but it does not extend beyond the uterus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage II","conceptCode":"C96252","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that invades beyond the cervix, but not to the pelvic wall or lower third of the vagina; for endometrial cancer, it refers to cancer that invades the stromal connective tissue of the cervix, but it does not extend beyond the uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-506B-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73C1C15-03EF-D771-E040-BB89AD430AF5","beginDate":"2010-06-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"Stage IA","valueDescription":"FIGO Stage IA","ValueMeaning":{"publicId":"3225681","version":"1","preferredName":"FIGO Stage IA","longName":"3225681","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to invasive cancer that is diagnosed microscopically only.  The stromal invasion has a maximum depth of 5.00 mm and a horizontal spread of 7.00 mm or less; for endometrial cancer, it refers to cancer limited to endometrium or invades less than one-half of the myometrium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IA","conceptCode":"C96245","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to invasive cancer that is diagnosed microscopically only.  The stromal invasion has a maximum depth of 5.00 mm and a horizontal spread of 7.00 mm or less; for endometrial cancer, it refers to cancer limited to endometrium or invades less than one-half of the myometrium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-516E-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73C1C15-03F9-D771-E040-BB89AD430AF5","beginDate":"2010-06-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"Stage IB","valueDescription":"FIGO Stage IB","ValueMeaning":{"publicId":"3225678","version":"1","preferredName":"FIGO Stage IB","longName":"3225678","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to invasive cancer that is clinically visible and is confined to the cervix or it is diagnosed microscopically and the stromal invasion is more than 5.00 mm and the horizontal spread is more than 7.00 mm; for endometrial cancer, it refers to cancer that is confined to the uterine body and invades one-half or more of the myometrium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IB","conceptCode":"C96248","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to invasive cancer that is clinically visible and is confined to the cervix or it is diagnosed microscopically and the stromal invasion is more than 5.00 mm and the horizontal spread is more than 7.00 mm; for endometrial cancer, it refers to cancer that is confined to the uterine body and invades one-half or more of the myometrium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-50FF-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73C1C15-0403-D771-E040-BB89AD430AF5","beginDate":"2010-06-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"Stage IIIA","valueDescription":"FIGO Stage IIIA","ValueMeaning":{"publicId":"3225670","version":"1","preferredName":"FIGO Stage IIIA","longName":"3225670","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that involves the lower third of vagina and there is no extension to the pelvic wall; for endometrial cancer, it refers to cancer with involvement of the serosa and/or the adnexa.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIIA","conceptCode":"C96256","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that involves the lower third of vagina and there is no extension to the pelvic wall; for endometrial cancer, it refers to cancer with involvement of the serosa and/or the adnexa.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4FD7-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73C1C15-040D-D771-E040-BB89AD430AF5","beginDate":"2010-06-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"Stage IIIB","valueDescription":"FIGO Stage IIIB","ValueMeaning":{"publicId":"3225669","version":"1","preferredName":"FIGO Stage IIIB","longName":"3225669","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that extends to the pelvic wall, and/or causes hydronephrosis or non-functioning kidney; for endometrial cancer, it refers to cancer with vaginal or parametrial involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIIB","conceptCode":"C96257","definition":"A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that extends to the pelvic wall, and/or causes hydronephrosis or non-functioning kidney; for endometrial cancer, it refers to cancer with vaginal or parametrial involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4FB2-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73C1C15-0417-D771-E040-BB89AD430AF5","beginDate":"2010-06-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"Stage IIIC1","valueDescription":"FIGO Stage IIIC1","ValueMeaning":{"publicId":"3225667","version":"1","preferredName":"FIGO Stage IIIC1","longName":"3225667","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  There is no FIGO stage IIIC1 for cervical cancer; for endometrial cancer, it refers to regional metastasis to pelvic lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIIC1","conceptCode":"C96259","definition":"A FIGO stage term that applies to gynecologic cancers.  There is no FIGO stage IIIC1 for cervical cancer; for endometrial cancer, it refers to regional metastasis to pelvic lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4F68-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73C1C15-0421-D771-E040-BB89AD430AF5","beginDate":"2010-06-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"Stage IIIC2","valueDescription":"FIGO Stage IIIC2","ValueMeaning":{"publicId":"3225666","version":"1","preferredName":"FIGO Stage IIIC2","longName":"3225666","preferredDefinition":"A FIGO stage term that applies to gynecologic cancers.  There is no FIGO stage IIIC2 for cervical cancer; for endometrial cancer, it refers to regional metastasis to para-aortic lymph nodes with or without metastasis to pelvic lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Stage IIIC2","conceptCode":"C96260","definition":"A FIGO stage term that applies to gynecologic cancers.  There is no FIGO stage IIIC2 for cervical cancer; for endometrial cancer, it refers to regional metastasis to para-aortic lymph nodes with or without metastasis to pelvic lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0338BA5-4F43-7BC8-E040-BB89AD4341A0","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73C1C15-042B-D771-E040-BB89AD430AF5","beginDate":"2010-10-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3108364","version":"1","preferredName":"Endometrial Carcinoma Stage","preferredDefinition":"A malignant tumor arising from the epithelium that lines the cavity of the uterine body.  The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases.  Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma.  Uterine bleeding is an initial clinical sign.  The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation. -- 2004:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C7558:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial Carcinoma","conceptCode":"C7558","definition":"A malignant tumor arising from the epithelium that lines the cavity of the uterine body.  The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases.  Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma.  Uterine bleeding is an initial clinical sign.  The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88885973-0E63-EC2B-E040-BB89AD432554","latestVersionIndicator":"Yes","beginDate":"2010-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-08","modifiedBy":"ONEDATA","dateModified":"2010-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"FIGO:International Federation of Gynecology and Obstretrics Endometrial Staging 2009","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C73C1C15-03D9-D771-E040-BB89AD430AF5","latestVersionIndicator":"Yes","beginDate":"2012-08-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"COOPERM","dateModified":"2012-08-14","changeDescription":"Added concept annotation to PVs and 2009 to long name as part of CRF standard harmonization. mc 6/4/12 Versioned for change in min/max length. mc 8/14/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3444894","version":"1","longName":"Corpus Uteri Carcinoma","context":"NCIP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000586","version":"1","longName":"FIGO","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000585","version":"1","longName":"FIGO","context":"NCI Standards"},{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"FIGO Stage","type":"Preferred Question Text","description":"FIGO Stage","url":null,"context":"NCI Standards"},{"name":"TCGA FIGO 2009 Endometrial Staging Guidelines","type":"REFERENCE","description":"International Federation of Gynecology and Obstetrics (FIGO) revised 2009 Endometrial Carcinoma Staging Criteria","url":"http://www.medscape.com/viewarticle/722721","context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"C73C1C15-0475-D771-E040-BB89AD430AF5","latestVersionIndicator":"Yes","beginDate":"2012-08-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 6/2010 Added 2009 to long name as part of CRF standard harmonization. mc 6/4/12 Versioned for change in VD min/max length. mc 8/14/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}